Significant publications on infectious diseases pharmacotherapy in 2015

Babic, Jessica T.; Sofjan, Amelia K.; Babin, Margaret; Echevarria, Kelly; Ikwuagwu, Judy O.; Lam, Wai-Ying M; Aitken, Samuel L; Perez, Katherine K.

doi:10.2146/ajhp160090

Cited by 17 publications

(10 citation statements)

References 89 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Six patients (0.8%) in the oral step-down group had recurrent 30-day bacteremia versus 4 (0.5%) in the IV group (HR, 0.82; 95% CI, 0.33-2.01). The median length of hospitalization was 5 (IQR, 3-8) vs 7 (IQR, [4][5][6][7][8][9][10][11][12][13][14] days in the oral step-down and IV groups, respectively (p < 0.001). The median duration of IV antibiotics in the oral step-down group was 3 days (IQR, 2-4 days) vs 14 days (IQR, 11-15 days) in the IV group.…”

Section: Tamma Et Al Association Of 30-day Mortality With Oralmentioning

confidence: 97%

“…To help alleviate this task, the Houston Infectious Diseases Network (HIDN) summarizes annually the prior year's most significant ID publications. [1][2][3][4][5][6][7][8][9][10][11][12] HIDN consists of ID clinicians from the Texas Medical Center in Houston, TX, and includes physicians, pharmacists, microbiologists, and researchers from over 15 institutions. The network regularly meets throughout the year to discuss collaborative efforts in best practices, education, research, and stewardship.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Significant Publications on Infectious Diseases Pharmacotherapy in 2019

Hendrickson

Spitznogle

Gonzales-Luna

et al. 2020

Journal of Pharmacy Practice

Self Cite

View full text Add to dashboard Cite

Purpose To provide a summary of the most prominent peer-reviewed infectious diseases (ID) pharmacotherapy and Human Immunodeficiency Virus (HIV)-related articles published in 2019. Summary Houston Infectious Diseases Network (HIDN) members were asked to nominate articles that they believed were most influential within the ID and HIV pharmacotherapy science communities. A total of 48 general ID and 6 HIV-related articles were nominated. Following nominations, an online survey was distributed via e-mail to Society of Infectious Diseases Pharmacists (SIDP) members, with a total of 156 and 54 members voting for general ID and HIV-related articles, respectively. The results of this survey were ranked to determine the top 10 general ID and top HIV articles. The top articles were then summarized by HIDN members, including residents, fellows, and clinical pharmacists. Conclusion This review covers many of the most influential ID articles published in 2019, including 3 practice guideline updates. Due to the high rate of ID literature published each year, this review continues to help summarize these articles for the ID community, allowing clinicians to remain up-to-date on practice-changing publications in ID and HIV pharmacotherapy.

show abstract

Section: Tamma Et Al Association Of 30-day Mortality With Oralmentioning

confidence: 97%

Section: Introductionmentioning

confidence: 99%

Significant Publications on Infectious Diseases Pharmacotherapy in 2019

Hendrickson

Spitznogle

Gonzales-Luna

et al. 2020

Journal of Pharmacy Practice

Self Cite

View full text Add to dashboard Cite

show abstract

“…Each year since 2009, the HIDN has led efforts to compile and review the top 10 significant publications in ID pharmacotherapy. [1][2][3][4][5][6][7][8][9] The purpose of this annual publication is to provide clinicians with an easily accessible summary of some of the most important developments in the field. Similar to previous years, at the end of 2018, HIDN members were asked to nominate articles thought to have most influenced ID pharmacotherapy practice in 2018, including those related to human immunodeficiency virus (HIV).…”

Section: Introductionmentioning

confidence: 99%

Significant Publications on Infectious Diseases Pharmacotherapy in 2018

Borjan

Gonzales-Luna

Carlson

et al. 2019

Journal of Pharmacy Practice

View full text Add to dashboard Cite

Purpose: To summarize the top 10 most influential peer-reviewed infectious diseases (ID) pharmacotherapy articles published in the year 2018. Summary: Members of the Houston Infectious Diseases Network (HIDN) nominated articles that were thought to have most notably contributed to ID pharmacotherapy in 2018, including those related to human immunodeficiency virus (HIV). A total of 26 articles were nominated: 22 articles pertaining to general ID pharmacotherapy and 4 articles involving HIV/AIDS. To select the most significant articles of 2018, a survey was created and distributed to members of the Society of Infectious Diseases Pharmacists (SIDP) asking members to vote on their top 10 general ID publications and 1 HIV publication. Of the 462 members surveyed, 213 (46%) and 108 (23%) voted for general ID pharmacotherapy- and HIV-related articles, respectively. The top article(s) for both categories are summarized. Conclusion: With the increased emphasis on antimicrobial stewardship initiatives and the growing problem of multidrug-resistant (MDR) organisms, the amount of ID literature centered on stewardship, appropriate treatment durations, and newly approved antimicrobial agents continues to expand, making it challenging for clinicians to stay informed on the most relevant publications. This review summarizes significant ID-related publications in 2018 with the goal of aiding clinicians in staying up to date on the most noteworthy publications in ID pharmacotherapy.

show abstract

“…As a continuation of prior efforts to summarize important recent ID pharmacotherapy-related publications, [1][2][3][4][5][6][7][8] members were asked to nominate peer-reviewed articles that they believed most contributed to the practice of ID pharmacotherapy in 2017, including the areas of human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS). All nominated articles were published between January 1, 2017, and December 31, 2017, in prominent peerreviewed journals (eg, Antimicrobial Agents and Chemotherapy, Clinical Infectious Diseases, Journal of the American Medical Association).…”

mentioning

confidence: 99%